Testing effectiveness (Phase 2)Ended earlyNCT04326439What this trial is testingAflacLL1901 (CHOA-AML)Who this might be right forAcute Myeloid LeukemiaAML, Childhood Emory University 8
Early research (Phase 1)WithdrawnNCT05487495What this trial is testingDonor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/LymphomaWho this might be right forT-Cell Acute Lymphoblastic Leukemia/Lymphoma Beijing Boren Hospital
Testing effectiveness (Phase 2)Study completedNCT01289457What this trial is testingClofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic SyndromeWho this might be right forLeukemia M.D. Anderson Cancer Center 282
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)UnknownNCT01513603What this trial is testingTrial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic LymphomaBurkitts Leukemia/Lymphoma+1 more New York Medical College 50
Early research (Phase 1)Ended earlyNCT00725062What this trial is testingDonor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Masonic Cancer Center, University of Minnesota 3
Early research (Phase 1)Study completedNCT00004862What this trial is testingAugmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT07500441What this trial is testingDigital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AMLWho this might be right forAcute Myeloid Leukemia (AML) Peking University People's Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02782546What this trial is testingCytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell TransplantationWho this might be right forAcute Myeloid Leukemia Washington University School of Medicine 60
Early research (Phase 1)Ended earlyNCT03755154What this trial is testingStudy of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic LeukemiaWho this might be right forRelapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Non-Hodgkin LymphomaRelapsed or Refractory Multiple Myeloma+1 more Institut de Recherches Internationales Servier 60
Large-scale testing (Phase 3)Looking for participantsNCT07583888What this trial is testingVABu Conditioning in Elderly AML HSCTWho this might be right forAllogeneic Hematopoietic Stem Cell Transplantation RecipientAcute Myeloid Leukemia (AML) The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05029141What this trial is testingNew Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaRefractory Acute LeukemiaRelapsed Adult AML The First Affiliated Hospital of Soochow University 21
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT02935361What this trial is testingGuadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or RelapsedWho this might be right forChronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes University of Southern California 33
Not applicableStudy completedNCT00386373What this trial is testingUse and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia PatientsWho this might be right forLeukemia M.D. Anderson Cancer Center 10
Early research (Phase 1)Study completedNCT04277442What this trial is testingTesting Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia National Cancer Institute (NCI) 1
Early research (Phase 1)Active Not RecruitingNCT04953780What this trial is testingPhase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Diagnosed AMLWho this might be right forAcute Myeloid Leukemia West Virginia University 6
Testing effectiveness (Phase 2)UnknownNCT01556477What this trial is testingThe Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).Who this might be right forMyelodysplastic SyndromeAcute Myelogenous Leukemia Nordic MDS Group 72
Testing effectiveness (Phase 2)Looking for participantsNCT05674175What this trial is testingCo-administration of CART22-65s and huCART19 for B-ALLWho this might be right forB-cell Acute Lymphoblastic LeukemiaB Lineage Lymphoblastic Lymphoma Stephan Grupp MD PhD 93
Testing effectiveness (Phase 2)Study completedNCT04323657What this trial is testingTC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+3 more TCR2 Therapeutics 6